Patents by Inventor Min Jeong Choi

Min Jeong Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250147787
    Abstract: A cloud integrated management system for providing integrated cloud services based on a container and a virtual machine according to an embodiment of the present disclosure may include: a worker module that operates at least one pod including at least one container; and a master module that receives a command of a manager and transmits the command of the manager to the worker module, wherein the master module may transmit the received command of the manager to the worker module and the virtual machine.
    Type: Application
    Filed: November 17, 2023
    Publication date: May 8, 2025
    Applicant: OKESTRO CO., LTD.
    Inventors: Chang Woo SONG, Myeong Kil KIM, Keun Su LEE, Min Jeong CHOI, Young Gwang KIM, Min Jun KIM
  • Publication number: 20240190925
    Abstract: The present invention relates to a novel signal sequence peptide and a vector comprising a polynucleotide encoding same. The signal sequence peptide can induce a protein linked thereto to be secreted to the outside of a cell, and thus, when the signal sequence peptide is used or a recombinant microorganism transformed with the vector is used, the signal sequence peptide expresses a target protein and then secretes the target protein to the outside of a cell, thus enabling the target protein to exhibit the activity and function thereof.
    Type: Application
    Filed: April 5, 2022
    Publication date: June 13, 2024
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Dae Hee LEE, Seung Goo LEE, Tae Hyun KIM, Seong Keun KIM, Min Jeong CHOI, Seung Gyun WOO, Hyun Seung LIM, Seokjin OH
  • Patent number: 9309515
    Abstract: Disclosed are a DNA aptamer specifically binding to the Her2 (ERBB2) receptor involved in the onset of breast cancer, a composition for the suppression of cancer metastasis comprising the same as an active ingredient, and a composition for the diagnosis of cancer comprising the same as an active ingredient. Due to its binding mechanism being different from that of the conventional antibody, the aptamer can be effectively used for suppressing cancer metastasis and diagnosing cancer.
    Type: Grant
    Filed: August 10, 2011
    Date of Patent: April 12, 2016
    Assignees: POSTECH ACADEMY-INDUSTRY FOUNDATION, KOREA FOOD & DRUG ADMINISTRATION
    Inventors: Jung Hwan Lee, Young Chan Chae, Youngdong Kim, Hyungu Kang, Jong Hun Im, Jong In Kim, Ki Seok Kim, Sung Key Jang, Il Ung Oh, Min Jeong Choi, Won Jun Kang
  • Publication number: 20150005368
    Abstract: Disclosed are a DNA aptamer specifically binding to the Her2 (ERBB2) receptor involved in the onset of breast cancer, a composition for the suppression of cancer metastasis comprising the same as an active ingredient, and a composition for the diagnosis of cancer comprising the same as an active ingredient. Due to its binding mechanism being different from that of the conventional antibody, the aptamer can be effectively used for suppressing cancer metastasis and diagnosing cancer.
    Type: Application
    Filed: August 10, 2011
    Publication date: January 1, 2015
    Applicants: KOREA FOOD & DRUG ADMINISTRATION, POSTECH ACADEMY-INDUSTRY FOUNDATION
    Inventors: Jung Hwan Lee, Young Chan Chae, Youndong Kim, Hyungu Kang, Jong Hun Im, Jong In Kim, Ki Seok Kim, Sung Key Jang, II Ung Oh, Min Jeong Choi, Won Jun Kang